Government moves to reduce the cost of PBS medicines 20 March 2025 The Federal Government has today that medicines on the Pharmaceutical Benefits Scheme (PBS) will cost no more than $25 from 1 January 2026. In a pre-election commitment that has been , the maximum cost of a PBS prescription will drop from $31.60 to $25. 芒果直播 Group CEO Justine Cain welcomed the announcement saying people taking diabetes medicines listed on the PBS will benefit from this cost of living relief. 鈥淎 person鈥檚 bank balance or postcode should not be a barrier to good health. We must ensure medicines are affordable for people who need them. 鈥淟ast year 芒果直播 undertook a cost of living survey which showed that for 61% of people, the cost of diabetes medicines and technologies was their greatest challenge. 鈥淟owering the cost of PBS medicines will help our community with the considerable strain of living with a chronic condition,鈥 Ms Cain said. Diabetes medicines included in the price change include Metformin, Semaglutide, Empagliflozin, Dapagliflozin, and Empagliflozin with metformin. The Federal Government said the investment will cost $689 million over four years and the changes would come into effect on 1 January 2026 in line with regular indexation.
News 26 August 2026 Deanne Minniecon appointed Adjunct Associate Professor, UQ Deanne Minniecon, Group Executive, Aboriginal and Torres Strait Islander Engagement, has been appointed as an聽Adjunct Associate Professor in the School of Public Health at the University of Queensland (UQ). Continue Reading
Blog 23 August 2026 Spring clean your diabetes routine Now is the perfect time to dust off a few healthy habits, refresh your routine, and head into the warmer months feeling your best. Continue Reading
Media releases 17 August 2026 芒果直播 to deliver Insulin Pump Program supporting children and young people 芒果直播 has been appointed to deliver the Commonwealth-funded Insulin Pump Program (IPP). Continue Reading